290 related articles for article (PubMed ID: 8941502)
1. Management of asthma with zafirlukast. Clinical experience and tolerability profile.
Spector SL
Drugs; 1996; 52 Suppl 6():36-46. PubMed ID: 8941502
[TBL] [Abstract][Full Text] [Related]
2. Zafirlukast: the first leukotriene-receptor antagonist approved for the treatment of asthma.
Kelloway JS
Ann Pharmacother; 1997 Sep; 31(9):1012-21. PubMed ID: 9296243
[TBL] [Abstract][Full Text] [Related]
3. Zafirlukast. A review of its pharmacology and therapeutic potential in the management of asthma.
Adkins JC; Brogden RN
Drugs; 1998 Jan; 55(1):121-44. PubMed ID: 9463793
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness of the leukotriene receptor antagonist zafirlukast for mild-to-moderate asthma. A randomized, double-blind, placebo-controlled trial.
Suissa S; Dennis R; Ernst P; Sheehy O; Wood-Dauphinee S
Ann Intern Med; 1997 Feb; 126(3):177-83. PubMed ID: 9027267
[TBL] [Abstract][Full Text] [Related]
5. Summary of clinical trials with zafirlukast.
Calhoun WJ
Am J Respir Crit Care Med; 1998 Jun; 157(6 Pt 2):S238-45; discussion S245-8. PubMed ID: 9647606
[TBL] [Abstract][Full Text] [Related]
6. [The role of leukotrienes in inflammation and leukotriene inhibitors].
Kupczyk M; Kuna P
Pol Merkur Lekarski; 1999 Sep; 7(39):85-93. PubMed ID: 10598480
[TBL] [Abstract][Full Text] [Related]
7. Leukotriene inhibitors and antagonists in asthma.
Spector SL
Ann Allergy Asthma Immunol; 1995 Dec; 75(6 Pt 1):463-70, 473; quiz 473-4. PubMed ID: 8603274
[TBL] [Abstract][Full Text] [Related]
8. Zafirlukast: an update of its pharmacology and therapeutic efficacy in asthma.
Dunn CJ; Goa KL
Drugs; 2001; 61(2):285-315. PubMed ID: 11270943
[TBL] [Abstract][Full Text] [Related]
9. Zafirlukast improves asthma control in patients receiving high-dose inhaled corticosteroids.
Virchow JC; Prasse A; Naya I; Summerton L; Harris A
Am J Respir Crit Care Med; 2000 Aug; 162(2 Pt 1):578-85. PubMed ID: 10934090
[TBL] [Abstract][Full Text] [Related]
10. Zafirlukast for symptomatic mild-to-moderate asthma: a 13-week multicenter study. The Zafirlukast Trialists Group.
Fish JE; Kemp JP; Lockey RF; Glass M; Hanby LA; Bonuccelli CM
Clin Ther; 1997; 19(4):675-90. PubMed ID: 9377612
[TBL] [Abstract][Full Text] [Related]
11. Comparison of inhaled salmeterol and oral zafirlukast in asthmatic patients using concomitant inhaled corticosteroids.
Nelson HS; Nathan RA; Kalberg C; Yancey SW; Rickard KA
MedGenMed; 2001 Jul; 3(4):3. PubMed ID: 11549982
[TBL] [Abstract][Full Text] [Related]
12. [Zafirlukast (Accolate): a review of its pharmacological and clinical profile].
Murata Y; Sugimoto O
Nihon Yakurigaku Zasshi; 2002 Apr; 119(4):247-58. PubMed ID: 11979731
[TBL] [Abstract][Full Text] [Related]
13. Pathophysiology of the cysteinyl leukotrienes and effects of leukotriene receptor antagonists in asthma.
Bisgaard H
Allergy; 2001; 56 Suppl 66():7-11. PubMed ID: 11421935
[TBL] [Abstract][Full Text] [Related]
14. An evaluation of zafirlukast in the treatment of asthma with exploratory subset analyses.
Tashkin DP; Nathan RA; Howland WC; Minkwitz MC; Simonson SG; Bonuccelli CM
J Allergy Clin Immunol; 1999 Feb; 103(2 Pt 1):246-54. PubMed ID: 9949315
[TBL] [Abstract][Full Text] [Related]
15. Enhanced prostaglandin E2 secretion in sputum from asthmatic patients after zafirlukast therapy.
Tsai JJ; Su YC; Chan SC; Ho CK; Feng TC
J Formos Med Assoc; 2001 Apr; 100(4):241-3. PubMed ID: 11393122
[TBL] [Abstract][Full Text] [Related]
16. Fluticasone propionate compared with zafirlukast in controlling persistent asthma: a randomized double-blind, placebo-controlled trial.
Busse W; Wolfe J; Storms W; Srebro S; Edwards L; Johnson M; Bowers BW; Rogenes PR; Rickard K
J Fam Pract; 2001 Jul; 50(7):595-602. PubMed ID: 11485708
[TBL] [Abstract][Full Text] [Related]
17. [New drugs in asthma treatment. Leukotriene receptor blockers and leukotriene synthesis inhibitors].
Männistö J; Haahtela T
Nord Med; 1997 Apr; 112(4):122-5. PubMed ID: 9198809
[TBL] [Abstract][Full Text] [Related]
18. The leukotriene receptor antagonist zafirlukast inhibits sulfur dioxide-induced bronchoconstriction in patients with asthma.
Lazarus SC; Wong HH; Watts MJ; Boushey HA; Lavins BJ; Minkwitz MC
Am J Respir Crit Care Med; 1997 Dec; 156(6):1725-30. PubMed ID: 9412547
[TBL] [Abstract][Full Text] [Related]
19. Zafirlukast for asthma.
Med Lett Drugs Ther; 1996 Dec; 38(990):111-2. PubMed ID: 8988153
[No Abstract] [Full Text] [Related]
20. Zafirlukast in clinical practice: results of the Accolate Clinical Experience and Pharmacoepidemiology Trial (ACCEPT) in patients with asthma.
Kemp JP; Korenblat PE; Scherger JE; Minkwitz M
J Fam Pract; 1999 Jun; 48(6):425-32. PubMed ID: 10386485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
